nodes	percent_of_prediction	percent_of_DWPC	metapath
Gadobenate Dimeglumine—ALB—hematologic cancer	0.401	1	CbGaD
Gadobenate Dimeglumine—ALB—Imatinib—hematologic cancer	0.0751	0.383	CbGbCtD
Gadobenate Dimeglumine—ALB—Prednisone—hematologic cancer	0.0495	0.252	CbGbCtD
Gadobenate Dimeglumine—ALB—Irinotecan—hematologic cancer	0.0469	0.239	CbGbCtD
Gadobenate Dimeglumine—ALB—Methotrexate—hematologic cancer	0.0248	0.126	CbGbCtD
Gadobenate Dimeglumine—ALB—Vitamin B12 Metabolism—CRP—hematologic cancer	4.58e-05	0.0057	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Folate Metabolism—SOD2—hematologic cancer	4.45e-05	0.00554	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—FOXA2 and FOXA3 transcription factor networks—CREB1—hematologic cancer	4.34e-05	0.0054	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Folate Metabolism—IL4—hematologic cancer	4.31e-05	0.00537	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Hemostasis—CD2—hematologic cancer	4.24e-05	0.00528	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Vitamin B12 Metabolism—ICAM1—hematologic cancer	4.21e-05	0.00524	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Platelet degranulation—PDGFA—hematologic cancer	4.2e-05	0.00522	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—SLC-mediated transmembrane transport—SLC26A4—hematologic cancer	4.15e-05	0.00516	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Platelet activation, signaling and aggregation—GNA13—hematologic cancer	4.02e-05	0.005	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Response to elevated platelet cytosolic Ca2+—PDGFA—hematologic cancer	4e-05	0.00498	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Folate Metabolism—MTHFR—hematologic cancer	3.92e-05	0.00488	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism of lipids and lipoproteins—PHYH—hematologic cancer	3.86e-05	0.0048	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Platelet activation, signaling and aggregation—JAK3—hematologic cancer	3.83e-05	0.00477	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Platelet degranulation—HGF—hematologic cancer	3.8e-05	0.00473	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Platelet activation, signaling and aggregation—CD9—hematologic cancer	3.78e-05	0.0047	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Vitamin B12 Metabolism—CCL2—hematologic cancer	3.77e-05	0.00469	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Folate Metabolism—CRP—hematologic cancer	3.73e-05	0.00464	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Response to elevated platelet cytosolic Ca2+—HGF—hematologic cancer	3.62e-05	0.00451	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Hemostasis—THPO—hematologic cancer	3.6e-05	0.00449	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Hemostasis—CD58—hematologic cancer	3.6e-05	0.00449	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Platelet activation, signaling and aggregation—IL3RA—hematologic cancer	3.58e-05	0.00445	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Selenium Micronutrient Network—SOD2—hematologic cancer	3.54e-05	0.0044	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism of lipids and lipoproteins—SMPD3—hematologic cancer	3.53e-05	0.00439	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Response to elevated platelet cytosolic Ca2+—PRKCG—hematologic cancer	3.46e-05	0.0043	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Folate Metabolism—ICAM1—hematologic cancer	3.43e-05	0.00427	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Transmembrane transport of small molecules—AQP9—hematologic cancer	3.36e-05	0.00418	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Platelet degranulation—PDGFB—hematologic cancer	3.27e-05	0.00407	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Hemostasis—SRGN—hematologic cancer	3.21e-05	0.004	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Vitamin B12 Metabolism—IFNG—hematologic cancer	3.2e-05	0.00399	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Transmembrane transport of small molecules—FXYD6—hematologic cancer	3.12e-05	0.00388	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Response to elevated platelet cytosolic Ca2+—PDGFB—hematologic cancer	3.12e-05	0.00388	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Selenium Micronutrient Network—MTHFR—hematologic cancer	3.11e-05	0.00387	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Folate Metabolism—CCL2—hematologic cancer	3.07e-05	0.00382	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Hemostasis—MPL—hematologic cancer	3.06e-05	0.00381	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Platelet activation, signaling and aggregation—RAC2—hematologic cancer	2.99e-05	0.00373	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Selenium Micronutrient Network—CRP—hematologic cancer	2.96e-05	0.00369	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Platelet degranulation—FN1—hematologic cancer	2.95e-05	0.00367	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Hemostasis—S100A10—hematologic cancer	2.94e-05	0.00366	CbGpPWpGaD
Gadobenate Dimeglumine—Mediastinal disorder—Epirubicin—hematologic cancer	2.91e-05	7.39e-05	CcSEcCtD
Gadobenate Dimeglumine—Gastrointestinal disorder—Betamethasone—hematologic cancer	2.91e-05	7.38e-05	CcSEcCtD
Gadobenate Dimeglumine—Gastrointestinal disorder—Dexamethasone—hematologic cancer	2.91e-05	7.38e-05	CcSEcCtD
Gadobenate Dimeglumine—Back pain—Methotrexate—hematologic cancer	2.91e-05	7.38e-05	CcSEcCtD
Gadobenate Dimeglumine—Fatigue—Dexamethasone—hematologic cancer	2.91e-05	7.37e-05	CcSEcCtD
Gadobenate Dimeglumine—Fatigue—Betamethasone—hematologic cancer	2.91e-05	7.37e-05	CcSEcCtD
Gadobenate Dimeglumine—Chills—Epirubicin—hematologic cancer	2.9e-05	7.36e-05	CcSEcCtD
Gadobenate Dimeglumine—Pruritus—Etoposide—hematologic cancer	2.9e-05	7.35e-05	CcSEcCtD
Gadobenate Dimeglumine—Shock—Prednisone—hematologic cancer	2.89e-05	7.33e-05	CcSEcCtD
Gadobenate Dimeglumine—Arrhythmia—Epirubicin—hematologic cancer	2.89e-05	7.32e-05	CcSEcCtD
Gadobenate Dimeglumine—Pain—Betamethasone—hematologic cancer	2.88e-05	7.31e-05	CcSEcCtD
Gadobenate Dimeglumine—Pain—Dexamethasone—hematologic cancer	2.88e-05	7.31e-05	CcSEcCtD
Gadobenate Dimeglumine—Visual impairment—Doxorubicin—hematologic cancer	2.88e-05	7.31e-05	CcSEcCtD
Gadobenate Dimeglumine—Nervous system disorder—Prednisone—hematologic cancer	2.88e-05	7.3e-05	CcSEcCtD
Gadobenate Dimeglumine—Tachycardia—Prednisone—hematologic cancer	2.87e-05	7.27e-05	CcSEcCtD
Gadobenate Dimeglumine—ALB—Vitamin B12 Metabolism—IL1B—hematologic cancer	2.86e-05	0.00356	CbGpPWpGaD
Gadobenate Dimeglumine—Skin disorder—Prednisone—hematologic cancer	2.85e-05	7.23e-05	CcSEcCtD
Gadobenate Dimeglumine—Nausea—Gemcitabine—hematologic cancer	2.85e-05	7.23e-05	CcSEcCtD
Gadobenate Dimeglumine—Vomiting—Cisplatin—hematologic cancer	2.84e-05	7.21e-05	CcSEcCtD
Gadobenate Dimeglumine—Hyperhidrosis—Prednisone—hematologic cancer	2.84e-05	7.2e-05	CcSEcCtD
Gadobenate Dimeglumine—Mental disorder—Epirubicin—hematologic cancer	2.83e-05	7.18e-05	CcSEcCtD
Gadobenate Dimeglumine—ALB—Hemostasis—GATA2—hematologic cancer	2.83e-05	0.00352	CbGpPWpGaD
Gadobenate Dimeglumine—Rash—Cisplatin—hematologic cancer	2.82e-05	7.15e-05	CcSEcCtD
Gadobenate Dimeglumine—Dermatitis—Cisplatin—hematologic cancer	2.82e-05	7.14e-05	CcSEcCtD
Gadobenate Dimeglumine—Erythema—Epirubicin—hematologic cancer	2.81e-05	7.14e-05	CcSEcCtD
Gadobenate Dimeglumine—Malnutrition—Epirubicin—hematologic cancer	2.81e-05	7.14e-05	CcSEcCtD
Gadobenate Dimeglumine—ALB—Response to elevated platelet cytosolic Ca2+—FN1—hematologic cancer	2.81e-05	0.0035	CbGpPWpGaD
Gadobenate Dimeglumine—Diarrhoea—Etoposide—hematologic cancer	2.8e-05	7.11e-05	CcSEcCtD
Gadobenate Dimeglumine—Eye disorder—Doxorubicin—hematologic cancer	2.8e-05	7.09e-05	CcSEcCtD
Gadobenate Dimeglumine—Ill-defined disorder—Methotrexate—hematologic cancer	2.79e-05	7.07e-05	CcSEcCtD
Gadobenate Dimeglumine—Tinnitus—Doxorubicin—hematologic cancer	2.79e-05	7.07e-05	CcSEcCtD
Gadobenate Dimeglumine—Anaemia—Methotrexate—hematologic cancer	2.78e-05	7.05e-05	CcSEcCtD
Gadobenate Dimeglumine—Feeling abnormal—Dexamethasone—hematologic cancer	2.78e-05	7.05e-05	CcSEcCtD
Gadobenate Dimeglumine—Feeling abnormal—Betamethasone—hematologic cancer	2.78e-05	7.05e-05	CcSEcCtD
Gadobenate Dimeglumine—Flushing—Doxorubicin—hematologic cancer	2.78e-05	7.04e-05	CcSEcCtD
Gadobenate Dimeglumine—Cardiac disorder—Doxorubicin—hematologic cancer	2.78e-05	7.04e-05	CcSEcCtD
Gadobenate Dimeglumine—Gastrointestinal pain—Dexamethasone—hematologic cancer	2.76e-05	6.99e-05	CcSEcCtD
Gadobenate Dimeglumine—Gastrointestinal pain—Betamethasone—hematologic cancer	2.76e-05	6.99e-05	CcSEcCtD
Gadobenate Dimeglumine—Dysgeusia—Epirubicin—hematologic cancer	2.76e-05	6.99e-05	CcSEcCtD
Gadobenate Dimeglumine—ALB—SLC-mediated transmembrane transport—SLC22A1—hematologic cancer	2.74e-05	0.00341	CbGpPWpGaD
Gadobenate Dimeglumine—Hypersensitivity—Triamcinolone—hematologic cancer	2.74e-05	6.94e-05	CcSEcCtD
Gadobenate Dimeglumine—Back pain—Epirubicin—hematologic cancer	2.72e-05	6.9e-05	CcSEcCtD
Gadobenate Dimeglumine—ALB—Selenium Micronutrient Network—ICAM1—hematologic cancer	2.72e-05	0.00339	CbGpPWpGaD
Gadobenate Dimeglumine—Angiopathy—Doxorubicin—hematologic cancer	2.71e-05	6.88e-05	CcSEcCtD
Gadobenate Dimeglumine—Malaise—Methotrexate—hematologic cancer	2.71e-05	6.88e-05	CcSEcCtD
Gadobenate Dimeglumine—Dizziness—Etoposide—hematologic cancer	2.71e-05	6.87e-05	CcSEcCtD
Gadobenate Dimeglumine—Muscle spasms—Epirubicin—hematologic cancer	2.71e-05	6.86e-05	CcSEcCtD
Gadobenate Dimeglumine—Immune system disorder—Doxorubicin—hematologic cancer	2.7e-05	6.85e-05	CcSEcCtD
Gadobenate Dimeglumine—Mediastinal disorder—Doxorubicin—hematologic cancer	2.7e-05	6.84e-05	CcSEcCtD
Gadobenate Dimeglumine—Leukopenia—Methotrexate—hematologic cancer	2.69e-05	6.83e-05	CcSEcCtD
Gadobenate Dimeglumine—Chills—Doxorubicin—hematologic cancer	2.68e-05	6.81e-05	CcSEcCtD
Gadobenate Dimeglumine—Urticaria—Betamethasone—hematologic cancer	2.68e-05	6.79e-05	CcSEcCtD
Gadobenate Dimeglumine—Urticaria—Dexamethasone—hematologic cancer	2.68e-05	6.79e-05	CcSEcCtD
Gadobenate Dimeglumine—Musculoskeletal discomfort—Prednisone—hematologic cancer	2.68e-05	6.78e-05	CcSEcCtD
Gadobenate Dimeglumine—Dizziness—Prednisolone—hematologic cancer	2.67e-05	6.78e-05	CcSEcCtD
Gadobenate Dimeglumine—Arrhythmia—Doxorubicin—hematologic cancer	2.67e-05	6.78e-05	CcSEcCtD
Gadobenate Dimeglumine—Asthenia—Triamcinolone—hematologic cancer	2.67e-05	6.76e-05	CcSEcCtD
Gadobenate Dimeglumine—Body temperature increased—Betamethasone—hematologic cancer	2.67e-05	6.76e-05	CcSEcCtD
Gadobenate Dimeglumine—Abdominal pain—Betamethasone—hematologic cancer	2.67e-05	6.76e-05	CcSEcCtD
Gadobenate Dimeglumine—Body temperature increased—Dexamethasone—hematologic cancer	2.67e-05	6.76e-05	CcSEcCtD
Gadobenate Dimeglumine—Abdominal pain—Dexamethasone—hematologic cancer	2.67e-05	6.76e-05	CcSEcCtD
Gadobenate Dimeglumine—Nausea—Cisplatin—hematologic cancer	2.66e-05	6.74e-05	CcSEcCtD
Gadobenate Dimeglumine—Paraesthesia—Prednisone—hematologic cancer	2.64e-05	6.69e-05	CcSEcCtD
Gadobenate Dimeglumine—Pruritus—Triamcinolone—hematologic cancer	2.63e-05	6.67e-05	CcSEcCtD
Gadobenate Dimeglumine—Cough—Methotrexate—hematologic cancer	2.62e-05	6.65e-05	CcSEcCtD
Gadobenate Dimeglumine—Mental disorder—Doxorubicin—hematologic cancer	2.62e-05	6.64e-05	CcSEcCtD
Gadobenate Dimeglumine—Ill-defined disorder—Epirubicin—hematologic cancer	2.61e-05	6.62e-05	CcSEcCtD
Gadobenate Dimeglumine—ALB—Folate Metabolism—IFNG—hematologic cancer	2.61e-05	0.00325	CbGpPWpGaD
Gadobenate Dimeglumine—Vomiting—Etoposide—hematologic cancer	2.61e-05	6.61e-05	CcSEcCtD
Gadobenate Dimeglumine—Malnutrition—Doxorubicin—hematologic cancer	2.6e-05	6.6e-05	CcSEcCtD
Gadobenate Dimeglumine—Erythema—Doxorubicin—hematologic cancer	2.6e-05	6.6e-05	CcSEcCtD
Gadobenate Dimeglumine—Anaemia—Epirubicin—hematologic cancer	2.6e-05	6.6e-05	CcSEcCtD
Gadobenate Dimeglumine—ALB—SLC-mediated transmembrane transport—NUP98—hematologic cancer	2.59e-05	0.00322	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Platelet activation, signaling and aggregation—SPARC—hematologic cancer	2.59e-05	0.00322	CbGpPWpGaD
Gadobenate Dimeglumine—Dyspepsia—Prednisone—hematologic cancer	2.59e-05	6.55e-05	CcSEcCtD
Gadobenate Dimeglumine—Rash—Etoposide—hematologic cancer	2.58e-05	6.55e-05	CcSEcCtD
Gadobenate Dimeglumine—Dermatitis—Etoposide—hematologic cancer	2.58e-05	6.54e-05	CcSEcCtD
Gadobenate Dimeglumine—ALB—Hemostasis—ATP1B1—hematologic cancer	2.57e-05	0.0032	CbGpPWpGaD
Gadobenate Dimeglumine—Headache—Etoposide—hematologic cancer	2.57e-05	6.51e-05	CcSEcCtD
Gadobenate Dimeglumine—Myalgia—Methotrexate—hematologic cancer	2.56e-05	6.49e-05	CcSEcCtD
Gadobenate Dimeglumine—Chest pain—Methotrexate—hematologic cancer	2.56e-05	6.49e-05	CcSEcCtD
Gadobenate Dimeglumine—Arthralgia—Methotrexate—hematologic cancer	2.56e-05	6.49e-05	CcSEcCtD
Gadobenate Dimeglumine—Dysgeusia—Doxorubicin—hematologic cancer	2.55e-05	6.47e-05	CcSEcCtD
Gadobenate Dimeglumine—Rash—Prednisolone—hematologic cancer	2.55e-05	6.46e-05	CcSEcCtD
Gadobenate Dimeglumine—Dermatitis—Prednisolone—hematologic cancer	2.55e-05	6.46e-05	CcSEcCtD
Gadobenate Dimeglumine—ALB—Transmembrane transport of small molecules—S100A10—hematologic cancer	2.54e-05	0.00317	CbGpPWpGaD
Gadobenate Dimeglumine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—hematologic cancer	2.54e-05	6.45e-05	CcSEcCtD
Gadobenate Dimeglumine—Malaise—Epirubicin—hematologic cancer	2.54e-05	6.43e-05	CcSEcCtD
Gadobenate Dimeglumine—Fatigue—Prednisone—hematologic cancer	2.53e-05	6.42e-05	CcSEcCtD
Gadobenate Dimeglumine—Headache—Prednisolone—hematologic cancer	2.53e-05	6.42e-05	CcSEcCtD
Gadobenate Dimeglumine—Discomfort—Methotrexate—hematologic cancer	2.53e-05	6.41e-05	CcSEcCtD
Gadobenate Dimeglumine—Syncope—Epirubicin—hematologic cancer	2.52e-05	6.4e-05	CcSEcCtD
Gadobenate Dimeglumine—Leukopenia—Epirubicin—hematologic cancer	2.52e-05	6.39e-05	CcSEcCtD
Gadobenate Dimeglumine—Back pain—Doxorubicin—hematologic cancer	2.52e-05	6.39e-05	CcSEcCtD
Gadobenate Dimeglumine—Constipation—Prednisone—hematologic cancer	2.51e-05	6.37e-05	CcSEcCtD
Gadobenate Dimeglumine—ALB—Platelet activation, signaling and aggregation—LCK—hematologic cancer	2.51e-05	0.00312	CbGpPWpGaD
Gadobenate Dimeglumine—Muscle spasms—Doxorubicin—hematologic cancer	2.5e-05	6.35e-05	CcSEcCtD
Gadobenate Dimeglumine—ALB—SLC-mediated transmembrane transport—NUP214—hematologic cancer	2.49e-05	0.0031	CbGpPWpGaD
Gadobenate Dimeglumine—Palpitations—Epirubicin—hematologic cancer	2.49e-05	6.31e-05	CcSEcCtD
Gadobenate Dimeglumine—ALB—Metabolism of lipids and lipoproteins—GBA—hematologic cancer	2.49e-05	0.00309	CbGpPWpGaD
Gadobenate Dimeglumine—Confusional state—Methotrexate—hematologic cancer	2.48e-05	6.27e-05	CcSEcCtD
Gadobenate Dimeglumine—Loss of consciousness—Epirubicin—hematologic cancer	2.47e-05	6.27e-05	CcSEcCtD
Gadobenate Dimeglumine—Dizziness—Triamcinolone—hematologic cancer	2.46e-05	6.23e-05	CcSEcCtD
Gadobenate Dimeglumine—Cough—Epirubicin—hematologic cancer	2.46e-05	6.23e-05	CcSEcCtD
Gadobenate Dimeglumine—Anaphylactic shock—Methotrexate—hematologic cancer	2.45e-05	6.22e-05	CcSEcCtD
Gadobenate Dimeglumine—Infection—Methotrexate—hematologic cancer	2.44e-05	6.18e-05	CcSEcCtD
Gadobenate Dimeglumine—ALB—Selenium Micronutrient Network—CCL2—hematologic cancer	2.44e-05	0.00303	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Hemostasis—GATA1—hematologic cancer	2.43e-05	0.00303	CbGpPWpGaD
Gadobenate Dimeglumine—Nausea—Etoposide—hematologic cancer	2.43e-05	6.17e-05	CcSEcCtD
Gadobenate Dimeglumine—Hypertension—Epirubicin—hematologic cancer	2.43e-05	6.16e-05	CcSEcCtD
Gadobenate Dimeglumine—ALB—Platelet activation, signaling and aggregation—HSPA5—hematologic cancer	2.42e-05	0.00301	CbGpPWpGaD
Gadobenate Dimeglumine—Feeling abnormal—Prednisone—hematologic cancer	2.42e-05	6.14e-05	CcSEcCtD
Gadobenate Dimeglumine—Asthenia—Dexamethasone—hematologic cancer	2.42e-05	6.13e-05	CcSEcCtD
Gadobenate Dimeglumine—Asthenia—Betamethasone—hematologic cancer	2.42e-05	6.13e-05	CcSEcCtD
Gadobenate Dimeglumine—Ill-defined disorder—Doxorubicin—hematologic cancer	2.42e-05	6.13e-05	CcSEcCtD
Gadobenate Dimeglumine—Nervous system disorder—Methotrexate—hematologic cancer	2.41e-05	6.1e-05	CcSEcCtD
Gadobenate Dimeglumine—Anaemia—Doxorubicin—hematologic cancer	2.41e-05	6.1e-05	CcSEcCtD
Gadobenate Dimeglumine—Gastrointestinal pain—Prednisone—hematologic cancer	2.4e-05	6.09e-05	CcSEcCtD
Gadobenate Dimeglumine—Nausea—Prednisolone—hematologic cancer	2.4e-05	6.09e-05	CcSEcCtD
Gadobenate Dimeglumine—Arthralgia—Epirubicin—hematologic cancer	2.4e-05	6.08e-05	CcSEcCtD
Gadobenate Dimeglumine—Chest pain—Epirubicin—hematologic cancer	2.4e-05	6.08e-05	CcSEcCtD
Gadobenate Dimeglumine—Myalgia—Epirubicin—hematologic cancer	2.4e-05	6.08e-05	CcSEcCtD
Gadobenate Dimeglumine—Anxiety—Epirubicin—hematologic cancer	2.39e-05	6.05e-05	CcSEcCtD
Gadobenate Dimeglumine—ALB—Platelet activation, signaling and aggregation—PRKCZ—hematologic cancer	2.39e-05	0.00297	CbGpPWpGaD
Gadobenate Dimeglumine—Pruritus—Betamethasone—hematologic cancer	2.39e-05	6.05e-05	CcSEcCtD
Gadobenate Dimeglumine—Pruritus—Dexamethasone—hematologic cancer	2.39e-05	6.05e-05	CcSEcCtD
Gadobenate Dimeglumine—Skin disorder—Methotrexate—hematologic cancer	2.38e-05	6.04e-05	CcSEcCtD
Gadobenate Dimeglumine—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—hematologic cancer	2.38e-05	6.03e-05	CcSEcCtD
Gadobenate Dimeglumine—Hyperhidrosis—Methotrexate—hematologic cancer	2.37e-05	6.02e-05	CcSEcCtD
Gadobenate Dimeglumine—Discomfort—Epirubicin—hematologic cancer	2.37e-05	6e-05	CcSEcCtD
Gadobenate Dimeglumine—ALB—Transmembrane transport of small molecules—SLC35B2—hematologic cancer	2.36e-05	0.00294	CbGpPWpGaD
Gadobenate Dimeglumine—Vomiting—Triamcinolone—hematologic cancer	2.36e-05	5.99e-05	CcSEcCtD
Gadobenate Dimeglumine—Malaise—Doxorubicin—hematologic cancer	2.35e-05	5.95e-05	CcSEcCtD
Gadobenate Dimeglumine—Rash—Triamcinolone—hematologic cancer	2.34e-05	5.94e-05	CcSEcCtD
Gadobenate Dimeglumine—Dry mouth—Epirubicin—hematologic cancer	2.34e-05	5.94e-05	CcSEcCtD
Gadobenate Dimeglumine—Dermatitis—Triamcinolone—hematologic cancer	2.34e-05	5.94e-05	CcSEcCtD
Gadobenate Dimeglumine—Syncope—Doxorubicin—hematologic cancer	2.34e-05	5.92e-05	CcSEcCtD
Gadobenate Dimeglumine—Urticaria—Prednisone—hematologic cancer	2.33e-05	5.92e-05	CcSEcCtD
Gadobenate Dimeglumine—Leukopenia—Doxorubicin—hematologic cancer	2.33e-05	5.91e-05	CcSEcCtD
Gadobenate Dimeglumine—Headache—Triamcinolone—hematologic cancer	2.33e-05	5.9e-05	CcSEcCtD
Gadobenate Dimeglumine—ALB—Folate Metabolism—IL1B—hematologic cancer	2.33e-05	0.00289	CbGpPWpGaD
Gadobenate Dimeglumine—Body temperature increased—Prednisone—hematologic cancer	2.32e-05	5.89e-05	CcSEcCtD
Gadobenate Dimeglumine—Abdominal pain—Prednisone—hematologic cancer	2.32e-05	5.89e-05	CcSEcCtD
Gadobenate Dimeglumine—ALB—Folate Metabolism—IL2—hematologic cancer	2.32e-05	0.00288	CbGpPWpGaD
Gadobenate Dimeglumine—Confusional state—Epirubicin—hematologic cancer	2.32e-05	5.87e-05	CcSEcCtD
Gadobenate Dimeglumine—Diarrhoea—Betamethasone—hematologic cancer	2.31e-05	5.85e-05	CcSEcCtD
Gadobenate Dimeglumine—Diarrhoea—Dexamethasone—hematologic cancer	2.31e-05	5.85e-05	CcSEcCtD
Gadobenate Dimeglumine—Palpitations—Doxorubicin—hematologic cancer	2.3e-05	5.83e-05	CcSEcCtD
Gadobenate Dimeglumine—Anaphylactic shock—Epirubicin—hematologic cancer	2.3e-05	5.82e-05	CcSEcCtD
Gadobenate Dimeglumine—Hypotension—Methotrexate—hematologic cancer	2.29e-05	5.82e-05	CcSEcCtD
Gadobenate Dimeglumine—Loss of consciousness—Doxorubicin—hematologic cancer	2.29e-05	5.8e-05	CcSEcCtD
Gadobenate Dimeglumine—Infection—Epirubicin—hematologic cancer	2.28e-05	5.79e-05	CcSEcCtD
Gadobenate Dimeglumine—Cough—Doxorubicin—hematologic cancer	2.27e-05	5.76e-05	CcSEcCtD
Gadobenate Dimeglumine—Shock—Epirubicin—hematologic cancer	2.26e-05	5.73e-05	CcSEcCtD
Gadobenate Dimeglumine—Nervous system disorder—Epirubicin—hematologic cancer	2.25e-05	5.71e-05	CcSEcCtD
Gadobenate Dimeglumine—Hypertension—Doxorubicin—hematologic cancer	2.25e-05	5.7e-05	CcSEcCtD
Gadobenate Dimeglumine—Tachycardia—Epirubicin—hematologic cancer	2.24e-05	5.68e-05	CcSEcCtD
Gadobenate Dimeglumine—Musculoskeletal discomfort—Methotrexate—hematologic cancer	2.24e-05	5.67e-05	CcSEcCtD
Gadobenate Dimeglumine—Skin disorder—Epirubicin—hematologic cancer	2.23e-05	5.66e-05	CcSEcCtD
Gadobenate Dimeglumine—Dizziness—Dexamethasone—hematologic cancer	2.23e-05	5.65e-05	CcSEcCtD
Gadobenate Dimeglumine—Dizziness—Betamethasone—hematologic cancer	2.23e-05	5.65e-05	CcSEcCtD
Gadobenate Dimeglumine—ALB—Hemostasis—ANXA2—hematologic cancer	2.23e-05	0.00277	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Transmembrane transport of small molecules—ATP1B1—hematologic cancer	2.22e-05	0.00277	CbGpPWpGaD
Gadobenate Dimeglumine—Hyperhidrosis—Epirubicin—hematologic cancer	2.22e-05	5.63e-05	CcSEcCtD
Gadobenate Dimeglumine—Myalgia—Doxorubicin—hematologic cancer	2.22e-05	5.62e-05	CcSEcCtD
Gadobenate Dimeglumine—Chest pain—Doxorubicin—hematologic cancer	2.22e-05	5.62e-05	CcSEcCtD
Gadobenate Dimeglumine—Arthralgia—Doxorubicin—hematologic cancer	2.22e-05	5.62e-05	CcSEcCtD
Gadobenate Dimeglumine—Anxiety—Doxorubicin—hematologic cancer	2.21e-05	5.6e-05	CcSEcCtD
Gadobenate Dimeglumine—Nausea—Triamcinolone—hematologic cancer	2.21e-05	5.6e-05	CcSEcCtD
Gadobenate Dimeglumine—Paraesthesia—Methotrexate—hematologic cancer	2.2e-05	5.59e-05	CcSEcCtD
Gadobenate Dimeglumine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—hematologic cancer	2.2e-05	5.58e-05	CcSEcCtD
Gadobenate Dimeglumine—Discomfort—Doxorubicin—hematologic cancer	2.19e-05	5.55e-05	CcSEcCtD
Gadobenate Dimeglumine—Dyspnoea—Methotrexate—hematologic cancer	2.19e-05	5.55e-05	CcSEcCtD
Gadobenate Dimeglumine—Somnolence—Methotrexate—hematologic cancer	2.18e-05	5.53e-05	CcSEcCtD
Gadobenate Dimeglumine—Dry mouth—Doxorubicin—hematologic cancer	2.17e-05	5.5e-05	CcSEcCtD
Gadobenate Dimeglumine—Hypersensitivity—Prednisone—hematologic cancer	2.16e-05	5.49e-05	CcSEcCtD
Gadobenate Dimeglumine—Dyspepsia—Methotrexate—hematologic cancer	2.16e-05	5.48e-05	CcSEcCtD
Gadobenate Dimeglumine—Hypotension—Epirubicin—hematologic cancer	2.15e-05	5.44e-05	CcSEcCtD
Gadobenate Dimeglumine—ALB—Platelet activation, signaling and aggregation—IL3—hematologic cancer	2.15e-05	0.00267	CbGpPWpGaD
Gadobenate Dimeglumine—Vomiting—Dexamethasone—hematologic cancer	2.14e-05	5.44e-05	CcSEcCtD
Gadobenate Dimeglumine—Vomiting—Betamethasone—hematologic cancer	2.14e-05	5.44e-05	CcSEcCtD
Gadobenate Dimeglumine—Confusional state—Doxorubicin—hematologic cancer	2.14e-05	5.43e-05	CcSEcCtD
Gadobenate Dimeglumine—Rash—Dexamethasone—hematologic cancer	2.13e-05	5.39e-05	CcSEcCtD
Gadobenate Dimeglumine—Rash—Betamethasone—hematologic cancer	2.13e-05	5.39e-05	CcSEcCtD
Gadobenate Dimeglumine—Anaphylactic shock—Doxorubicin—hematologic cancer	2.13e-05	5.39e-05	CcSEcCtD
Gadobenate Dimeglumine—Dermatitis—Dexamethasone—hematologic cancer	2.12e-05	5.39e-05	CcSEcCtD
Gadobenate Dimeglumine—Dermatitis—Betamethasone—hematologic cancer	2.12e-05	5.39e-05	CcSEcCtD
Gadobenate Dimeglumine—Gastrointestinal disorder—Methotrexate—hematologic cancer	2.12e-05	5.37e-05	CcSEcCtD
Gadobenate Dimeglumine—Fatigue—Methotrexate—hematologic cancer	2.12e-05	5.37e-05	CcSEcCtD
Gadobenate Dimeglumine—Headache—Dexamethasone—hematologic cancer	2.11e-05	5.36e-05	CcSEcCtD
Gadobenate Dimeglumine—Headache—Betamethasone—hematologic cancer	2.11e-05	5.36e-05	CcSEcCtD
Gadobenate Dimeglumine—Infection—Doxorubicin—hematologic cancer	2.11e-05	5.35e-05	CcSEcCtD
Gadobenate Dimeglumine—ALB—Platelet activation, signaling and aggregation—PTPN1—hematologic cancer	2.11e-05	0.00263	CbGpPWpGaD
Gadobenate Dimeglumine—Asthenia—Prednisone—hematologic cancer	2.11e-05	5.34e-05	CcSEcCtD
Gadobenate Dimeglumine—ALB—Transmembrane transport of small molecules—SLC26A4—hematologic cancer	2.11e-05	0.00262	CbGpPWpGaD
Gadobenate Dimeglumine—Pain—Methotrexate—hematologic cancer	2.1e-05	5.32e-05	CcSEcCtD
Gadobenate Dimeglumine—Musculoskeletal discomfort—Epirubicin—hematologic cancer	2.09e-05	5.31e-05	CcSEcCtD
Gadobenate Dimeglumine—Shock—Doxorubicin—hematologic cancer	2.09e-05	5.3e-05	CcSEcCtD
Gadobenate Dimeglumine—Nervous system disorder—Doxorubicin—hematologic cancer	2.08e-05	5.28e-05	CcSEcCtD
Gadobenate Dimeglumine—Pruritus—Prednisone—hematologic cancer	2.08e-05	5.27e-05	CcSEcCtD
Gadobenate Dimeglumine—ALB—Platelet activation, signaling and aggregation—RASGRP1—hematologic cancer	2.08e-05	0.00258	CbGpPWpGaD
Gadobenate Dimeglumine—Tachycardia—Doxorubicin—hematologic cancer	2.07e-05	5.26e-05	CcSEcCtD
Gadobenate Dimeglumine—ALB—Vitamin B12 Metabolism—TNF—hematologic cancer	2.07e-05	0.00258	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Selenium Micronutrient Network—IFNG—hematologic cancer	2.07e-05	0.00258	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Hemostasis—GNA13—hematologic cancer	2.07e-05	0.00258	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Platelet activation, signaling and aggregation—SYK—hematologic cancer	2.07e-05	0.00257	CbGpPWpGaD
Gadobenate Dimeglumine—Skin disorder—Doxorubicin—hematologic cancer	2.06e-05	5.23e-05	CcSEcCtD
Gadobenate Dimeglumine—Paraesthesia—Epirubicin—hematologic cancer	2.06e-05	5.23e-05	CcSEcCtD
Gadobenate Dimeglumine—Hyperhidrosis—Doxorubicin—hematologic cancer	2.05e-05	5.21e-05	CcSEcCtD
Gadobenate Dimeglumine—Dyspnoea—Epirubicin—hematologic cancer	2.05e-05	5.19e-05	CcSEcCtD
Gadobenate Dimeglumine—Somnolence—Epirubicin—hematologic cancer	2.04e-05	5.18e-05	CcSEcCtD
Gadobenate Dimeglumine—ALB—Metabolism of lipids and lipoproteins—FHL2—hematologic cancer	2.03e-05	0.00252	CbGpPWpGaD
Gadobenate Dimeglumine—Feeling abnormal—Methotrexate—hematologic cancer	2.02e-05	5.13e-05	CcSEcCtD
Gadobenate Dimeglumine—Dyspepsia—Epirubicin—hematologic cancer	2.02e-05	5.13e-05	CcSEcCtD
Gadobenate Dimeglumine—Diarrhoea—Prednisone—hematologic cancer	2.01e-05	5.09e-05	CcSEcCtD
Gadobenate Dimeglumine—Gastrointestinal pain—Methotrexate—hematologic cancer	2.01e-05	5.09e-05	CcSEcCtD
Gadobenate Dimeglumine—Nausea—Dexamethasone—hematologic cancer	2e-05	5.08e-05	CcSEcCtD
Gadobenate Dimeglumine—Nausea—Betamethasone—hematologic cancer	2e-05	5.08e-05	CcSEcCtD
Gadobenate Dimeglumine—Hypotension—Doxorubicin—hematologic cancer	1.99e-05	5.04e-05	CcSEcCtD
Gadobenate Dimeglumine—Gastrointestinal disorder—Epirubicin—hematologic cancer	1.98e-05	5.03e-05	CcSEcCtD
Gadobenate Dimeglumine—Fatigue—Epirubicin—hematologic cancer	1.98e-05	5.02e-05	CcSEcCtD
Gadobenate Dimeglumine—ALB—Hemostasis—JAK3—hematologic cancer	1.97e-05	0.00246	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Hemostasis—ITGAX—hematologic cancer	1.97e-05	0.00246	CbGpPWpGaD
Gadobenate Dimeglumine—Constipation—Epirubicin—hematologic cancer	1.96e-05	4.98e-05	CcSEcCtD
Gadobenate Dimeglumine—Pain—Epirubicin—hematologic cancer	1.96e-05	4.98e-05	CcSEcCtD
Gadobenate Dimeglumine—Urticaria—Methotrexate—hematologic cancer	1.95e-05	4.94e-05	CcSEcCtD
Gadobenate Dimeglumine—ALB—Hemostasis—CD9—hematologic cancer	1.95e-05	0.00242	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Hemostasis—F3—hematologic cancer	1.95e-05	0.00242	CbGpPWpGaD
Gadobenate Dimeglumine—Dizziness—Prednisone—hematologic cancer	1.94e-05	4.92e-05	CcSEcCtD
Gadobenate Dimeglumine—Abdominal pain—Methotrexate—hematologic cancer	1.94e-05	4.92e-05	CcSEcCtD
Gadobenate Dimeglumine—Body temperature increased—Methotrexate—hematologic cancer	1.94e-05	4.92e-05	CcSEcCtD
Gadobenate Dimeglumine—Musculoskeletal discomfort—Doxorubicin—hematologic cancer	1.94e-05	4.91e-05	CcSEcCtD
Gadobenate Dimeglumine—ALB—Transmembrane transport of small molecules—SGK1—hematologic cancer	1.93e-05	0.0024	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Transmembrane transport of small molecules—ATP4A—hematologic cancer	1.93e-05	0.0024	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Transmembrane transport of small molecules—ANXA2—hematologic cancer	1.93e-05	0.0024	CbGpPWpGaD
Gadobenate Dimeglumine—Paraesthesia—Doxorubicin—hematologic cancer	1.91e-05	4.84e-05	CcSEcCtD
Gadobenate Dimeglumine—Dyspnoea—Doxorubicin—hematologic cancer	1.9e-05	4.8e-05	CcSEcCtD
Gadobenate Dimeglumine—ALB—Hemostasis—SELL—hematologic cancer	1.89e-05	0.00236	CbGpPWpGaD
Gadobenate Dimeglumine—Feeling abnormal—Epirubicin—hematologic cancer	1.89e-05	4.8e-05	CcSEcCtD
Gadobenate Dimeglumine—Somnolence—Doxorubicin—hematologic cancer	1.89e-05	4.79e-05	CcSEcCtD
Gadobenate Dimeglumine—Gastrointestinal pain—Epirubicin—hematologic cancer	1.88e-05	4.76e-05	CcSEcCtD
Gadobenate Dimeglumine—Dyspepsia—Doxorubicin—hematologic cancer	1.87e-05	4.74e-05	CcSEcCtD
Gadobenate Dimeglumine—Vomiting—Prednisone—hematologic cancer	1.87e-05	4.73e-05	CcSEcCtD
Gadobenate Dimeglumine—ALB—Platelet activation, signaling and aggregation—GRB2—hematologic cancer	1.87e-05	0.00232	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Platelet activation, signaling and aggregation—PDGFA—hematologic cancer	1.86e-05	0.00232	CbGpPWpGaD
Gadobenate Dimeglumine—Rash—Prednisone—hematologic cancer	1.85e-05	4.7e-05	CcSEcCtD
Gadobenate Dimeglumine—Dermatitis—Prednisone—hematologic cancer	1.85e-05	4.69e-05	CcSEcCtD
Gadobenate Dimeglumine—ALB—Selenium Micronutrient Network—IL1B—hematologic cancer	1.85e-05	0.0023	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Hemostasis—IL3RA—hematologic cancer	1.84e-05	0.0023	CbGpPWpGaD
Gadobenate Dimeglumine—Headache—Prednisone—hematologic cancer	1.84e-05	4.66e-05	CcSEcCtD
Gadobenate Dimeglumine—Gastrointestinal disorder—Doxorubicin—hematologic cancer	1.84e-05	4.65e-05	CcSEcCtD
Gadobenate Dimeglumine—Fatigue—Doxorubicin—hematologic cancer	1.83e-05	4.65e-05	CcSEcCtD
Gadobenate Dimeglumine—Urticaria—Epirubicin—hematologic cancer	1.83e-05	4.63e-05	CcSEcCtD
Gadobenate Dimeglumine—Constipation—Doxorubicin—hematologic cancer	1.82e-05	4.61e-05	CcSEcCtD
Gadobenate Dimeglumine—Pain—Doxorubicin—hematologic cancer	1.82e-05	4.61e-05	CcSEcCtD
Gadobenate Dimeglumine—Abdominal pain—Epirubicin—hematologic cancer	1.82e-05	4.6e-05	CcSEcCtD
Gadobenate Dimeglumine—Body temperature increased—Epirubicin—hematologic cancer	1.82e-05	4.6e-05	CcSEcCtD
Gadobenate Dimeglumine—Hypersensitivity—Methotrexate—hematologic cancer	1.81e-05	4.58e-05	CcSEcCtD
Gadobenate Dimeglumine—ALB—Metabolism of lipids and lipoproteins—ARNTL—hematologic cancer	1.77e-05	0.00221	CbGpPWpGaD
Gadobenate Dimeglumine—Asthenia—Methotrexate—hematologic cancer	1.76e-05	4.46e-05	CcSEcCtD
Gadobenate Dimeglumine—Feeling abnormal—Doxorubicin—hematologic cancer	1.75e-05	4.44e-05	CcSEcCtD
Gadobenate Dimeglumine—Nausea—Prednisone—hematologic cancer	1.74e-05	4.42e-05	CcSEcCtD
Gadobenate Dimeglumine—Gastrointestinal pain—Doxorubicin—hematologic cancer	1.74e-05	4.41e-05	CcSEcCtD
Gadobenate Dimeglumine—ALB—FOXA2 and FOXA3 transcription factor networks—AKT1—hematologic cancer	1.74e-05	0.00216	CbGpPWpGaD
Gadobenate Dimeglumine—Pruritus—Methotrexate—hematologic cancer	1.74e-05	4.4e-05	CcSEcCtD
Gadobenate Dimeglumine—ALB—Transmembrane transport of small molecules—TUBB2A—hematologic cancer	1.74e-05	0.00216	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism—FTCD—hematologic cancer	1.72e-05	0.00214	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism—GMPS—hematologic cancer	1.72e-05	0.00214	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism—PHYH—hematologic cancer	1.72e-05	0.00214	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism of lipids and lipoproteins—NCOR2—hematologic cancer	1.7e-05	0.00212	CbGpPWpGaD
Gadobenate Dimeglumine—Hypersensitivity—Epirubicin—hematologic cancer	1.69e-05	4.29e-05	CcSEcCtD
Gadobenate Dimeglumine—Urticaria—Doxorubicin—hematologic cancer	1.69e-05	4.28e-05	CcSEcCtD
Gadobenate Dimeglumine—ALB—Platelet degranulation—VEGFA—hematologic cancer	1.69e-05	0.0021	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Folate Metabolism—TNF—hematologic cancer	1.69e-05	0.0021	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Hemostasis—H3F3B—hematologic cancer	1.69e-05	0.0021	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Hemostasis—FGR—hematologic cancer	1.69e-05	0.0021	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Platelet activation, signaling and aggregation—HGF—hematologic cancer	1.69e-05	0.0021	CbGpPWpGaD
Gadobenate Dimeglumine—Body temperature increased—Doxorubicin—hematologic cancer	1.68e-05	4.26e-05	CcSEcCtD
Gadobenate Dimeglumine—Abdominal pain—Doxorubicin—hematologic cancer	1.68e-05	4.26e-05	CcSEcCtD
Gadobenate Dimeglumine—Diarrhoea—Methotrexate—hematologic cancer	1.68e-05	4.26e-05	CcSEcCtD
Gadobenate Dimeglumine—ALB—Vitamin B12 Metabolism—IL6—hematologic cancer	1.67e-05	0.00208	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Platelet activation, signaling and aggregation—CSF2—hematologic cancer	1.67e-05	0.00208	CbGpPWpGaD
Gadobenate Dimeglumine—Asthenia—Epirubicin—hematologic cancer	1.65e-05	4.18e-05	CcSEcCtD
Gadobenate Dimeglumine—Pruritus—Epirubicin—hematologic cancer	1.63e-05	4.12e-05	CcSEcCtD
Gadobenate Dimeglumine—ALB—Hemostasis—MYB—hematologic cancer	1.62e-05	0.00202	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Hemostasis—ITGAL—hematologic cancer	1.62e-05	0.00202	CbGpPWpGaD
Gadobenate Dimeglumine—Dizziness—Methotrexate—hematologic cancer	1.62e-05	4.12e-05	CcSEcCtD
Gadobenate Dimeglumine—ALB—Metabolism of lipids and lipoproteins—IDH1—hematologic cancer	1.62e-05	0.00202	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Platelet activation, signaling and aggregation—JAK1—hematologic cancer	1.61e-05	0.002	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Platelet activation, signaling and aggregation—PRKCG—hematologic cancer	1.61e-05	0.002	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Response to elevated platelet cytosolic Ca2+—VEGFA—hematologic cancer	1.61e-05	0.002	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism of lipids and lipoproteins—ABCC3—hematologic cancer	1.6e-05	0.00199	CbGpPWpGaD
Gadobenate Dimeglumine—Diarrhoea—Epirubicin—hematologic cancer	1.57e-05	3.98e-05	CcSEcCtD
Gadobenate Dimeglumine—ALB—Metabolism—SMPD3—hematologic cancer	1.57e-05	0.00196	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism of lipids and lipoproteins—SPHK1—hematologic cancer	1.57e-05	0.00195	CbGpPWpGaD
Gadobenate Dimeglumine—Hypersensitivity—Doxorubicin—hematologic cancer	1.57e-05	3.97e-05	CcSEcCtD
Gadobenate Dimeglumine—Vomiting—Methotrexate—hematologic cancer	1.56e-05	3.96e-05	CcSEcCtD
Gadobenate Dimeglumine—ALB—Platelet degranulation—TGFB1—hematologic cancer	1.55e-05	0.00193	CbGpPWpGaD
Gadobenate Dimeglumine—Rash—Methotrexate—hematologic cancer	1.55e-05	3.92e-05	CcSEcCtD
Gadobenate Dimeglumine—Dermatitis—Methotrexate—hematologic cancer	1.55e-05	3.92e-05	CcSEcCtD
Gadobenate Dimeglumine—ALB—Hemostasis—RAC2—hematologic cancer	1.54e-05	0.00192	CbGpPWpGaD
Gadobenate Dimeglumine—Headache—Methotrexate—hematologic cancer	1.54e-05	3.9e-05	CcSEcCtD
Gadobenate Dimeglumine—Asthenia—Doxorubicin—hematologic cancer	1.53e-05	3.87e-05	CcSEcCtD
Gadobenate Dimeglumine—ALB—Transmembrane transport of small molecules—ABCC3—hematologic cancer	1.52e-05	0.0019	CbGpPWpGaD
Gadobenate Dimeglumine—Dizziness—Epirubicin—hematologic cancer	1.52e-05	3.85e-05	CcSEcCtD
Gadobenate Dimeglumine—Pruritus—Doxorubicin—hematologic cancer	1.5e-05	3.81e-05	CcSEcCtD
Gadobenate Dimeglumine—ALB—Platelet activation, signaling and aggregation—IL2RA—hematologic cancer	1.5e-05	0.00187	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Folate Metabolism—TP53—hematologic cancer	1.49e-05	0.00185	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Response to elevated platelet cytosolic Ca2+—TGFB1—hematologic cancer	1.48e-05	0.00184	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism of lipids and lipoproteins—CRABP1—hematologic cancer	1.47e-05	0.00182	CbGpPWpGaD
Gadobenate Dimeglumine—Vomiting—Epirubicin—hematologic cancer	1.46e-05	3.7e-05	CcSEcCtD
Gadobenate Dimeglumine—Nausea—Methotrexate—hematologic cancer	1.46e-05	3.7e-05	CcSEcCtD
Gadobenate Dimeglumine—Diarrhoea—Doxorubicin—hematologic cancer	1.45e-05	3.69e-05	CcSEcCtD
Gadobenate Dimeglumine—ALB—Platelet activation, signaling and aggregation—PDGFB—hematologic cancer	1.45e-05	0.00181	CbGpPWpGaD
Gadobenate Dimeglumine—Rash—Epirubicin—hematologic cancer	1.45e-05	3.67e-05	CcSEcCtD
Gadobenate Dimeglumine—Dermatitis—Epirubicin—hematologic cancer	1.45e-05	3.67e-05	CcSEcCtD
Gadobenate Dimeglumine—Headache—Epirubicin—hematologic cancer	1.44e-05	3.65e-05	CcSEcCtD
Gadobenate Dimeglumine—ALB—Metabolism of lipids and lipoproteins—ALOX5—hematologic cancer	1.43e-05	0.00178	CbGpPWpGaD
Gadobenate Dimeglumine—Dizziness—Doxorubicin—hematologic cancer	1.41e-05	3.56e-05	CcSEcCtD
Gadobenate Dimeglumine—ALB—Hemostasis—SH2B3—hematologic cancer	1.4e-05	0.00174	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Transmembrane transport of small molecules—SLC22A1—hematologic cancer	1.39e-05	0.00173	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism—B3GAT1—hematologic cancer	1.37e-05	0.00171	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism—DCK—hematologic cancer	1.37e-05	0.00171	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism—ASNS—hematologic cancer	1.37e-05	0.00171	CbGpPWpGaD
Gadobenate Dimeglumine—Nausea—Epirubicin—hematologic cancer	1.36e-05	3.46e-05	CcSEcCtD
Gadobenate Dimeglumine—ALB—Folate Metabolism—IL6—hematologic cancer	1.36e-05	0.0017	CbGpPWpGaD
Gadobenate Dimeglumine—Vomiting—Doxorubicin—hematologic cancer	1.35e-05	3.43e-05	CcSEcCtD
Gadobenate Dimeglumine—ALB—Platelet activation, signaling and aggregation—MAPK14—hematologic cancer	1.35e-05	0.00168	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism of lipids and lipoproteins—NCOA3—hematologic cancer	1.34e-05	0.00167	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Selenium Micronutrient Network—TNF—hematologic cancer	1.34e-05	0.00167	CbGpPWpGaD
Gadobenate Dimeglumine—Rash—Doxorubicin—hematologic cancer	1.34e-05	3.4e-05	CcSEcCtD
Gadobenate Dimeglumine—Dermatitis—Doxorubicin—hematologic cancer	1.34e-05	3.39e-05	CcSEcCtD
Gadobenate Dimeglumine—ALB—Hemostasis—SPARC—hematologic cancer	1.33e-05	0.00166	CbGpPWpGaD
Gadobenate Dimeglumine—Headache—Doxorubicin—hematologic cancer	1.33e-05	3.38e-05	CcSEcCtD
Gadobenate Dimeglumine—ALB—Transmembrane transport of small molecules—NUP98—hematologic cancer	1.32e-05	0.00164	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Platelet activation, signaling and aggregation—FN1—hematologic cancer	1.31e-05	0.00163	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism—HDC—hematologic cancer	1.3e-05	0.00162	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Hemostasis—LCK—hematologic cancer	1.29e-05	0.00161	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Transmembrane transport of small molecules—ADCY7—hematologic cancer	1.28e-05	0.00159	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Transmembrane transport of small molecules—NUP214—hematologic cancer	1.27e-05	0.00158	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Hemostasis—H3F3A—hematologic cancer	1.27e-05	0.00158	CbGpPWpGaD
Gadobenate Dimeglumine—Nausea—Doxorubicin—hematologic cancer	1.26e-05	3.2e-05	CcSEcCtD
Gadobenate Dimeglumine—ALB—Hemostasis—GATA3—hematologic cancer	1.25e-05	0.00156	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Platelet activation, signaling and aggregation—PIK3CG—hematologic cancer	1.25e-05	0.00156	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Hemostasis—HSPA5—hematologic cancer	1.25e-05	0.00155	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Transmembrane transport of small molecules—ABCG2—hematologic cancer	1.24e-05	0.00155	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Hemostasis—PRKCZ—hematologic cancer	1.23e-05	0.00153	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism of lipids and lipoproteins—SDC1—hematologic cancer	1.21e-05	0.00151	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism—CDA—hematologic cancer	1.19e-05	0.00148	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Hemostasis—HDAC2—hematologic cancer	1.15e-05	0.00143	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism—PC—hematologic cancer	1.15e-05	0.00143	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Hemostasis—CD44—hematologic cancer	1.13e-05	0.00141	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Hemostasis—ITGA4—hematologic cancer	1.13e-05	0.00141	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism—GBA—hematologic cancer	1.11e-05	0.00138	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism—SLC35B2—hematologic cancer	1.11e-05	0.00138	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Transmembrane transport of small molecules—TFRC—hematologic cancer	1.11e-05	0.00138	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Hemostasis—IL3—hematologic cancer	1.11e-05	0.00138	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Platelet activation, signaling and aggregation—PIK3CD—hematologic cancer	1.1e-05	0.00137	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Hemostasis—IFNA1—hematologic cancer	1.1e-05	0.00137	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Hemostasis—PTPN1—hematologic cancer	1.09e-05	0.00135	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Selenium Micronutrient Network—IL6—hematologic cancer	1.08e-05	0.00135	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Hemostasis—RASGRP1—hematologic cancer	1.07e-05	0.00133	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Hemostasis—SYK—hematologic cancer	1.07e-05	0.00133	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Platelet activation, signaling and aggregation—PIK3R1—hematologic cancer	1.04e-05	0.00129	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Hemostasis—IFNA2—hematologic cancer	1.02e-05	0.00127	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism—MTAP—hematologic cancer	1.01e-05	0.00126	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Platelet activation, signaling and aggregation—JAK2—hematologic cancer	1.01e-05	0.00126	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Hemostasis—GRB2—hematologic cancer	9.62e-06	0.0012	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Hemostasis—PDGFA—hematologic cancer	9.6e-06	0.00119	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Platelet activation, signaling and aggregation—PIK3CB—hematologic cancer	9.6e-06	0.00119	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Transmembrane transport of small molecules—CYCS—hematologic cancer	9.29e-06	0.00116	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Hemostasis—ABL1—hematologic cancer	9.25e-06	0.00115	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism—FHL2—hematologic cancer	9.03e-06	0.00112	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism—AGRN—hematologic cancer	8.85e-06	0.0011	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Platelet activation, signaling and aggregation—IL2—hematologic cancer	8.81e-06	0.0011	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Hemostasis—HGF—hematologic cancer	8.69e-06	0.00108	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Hemostasis—CSF2—hematologic cancer	8.6e-06	0.00107	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism—HMMR—hematologic cancer	8.39e-06	0.00104	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism—IDH2—hematologic cancer	8.39e-06	0.00104	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Hemostasis—JAK1—hematologic cancer	8.3e-06	0.00103	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Hemostasis—PRKCG—hematologic cancer	8.3e-06	0.00103	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism of lipids and lipoproteins—NCOR1—hematologic cancer	7.91e-06	0.000985	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism—ARNTL—hematologic cancer	7.89e-06	0.000982	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Transmembrane transport of small molecules—ABCB1—hematologic cancer	7.75e-06	0.000965	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Hemostasis—IL2RA—hematologic cancer	7.75e-06	0.000964	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Platelet activation, signaling and aggregation—SRC—hematologic cancer	7.69e-06	0.000957	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism—CA9—hematologic cancer	7.68e-06	0.000955	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism—ACP5—hematologic cancer	7.68e-06	0.000955	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism—NCOR2—hematologic cancer	7.58e-06	0.000943	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Platelet activation, signaling and aggregation—VEGFA—hematologic cancer	7.49e-06	0.000932	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Hemostasis—PDGFB—hematologic cancer	7.48e-06	0.000931	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Hemostasis—CDK2—hematologic cancer	7.26e-06	0.000903	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism—IDH1—hematologic cancer	7.22e-06	0.000898	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism—ABCC3—hematologic cancer	7.14e-06	0.000888	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism—GSTO1—hematologic cancer	7.14e-06	0.000888	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism—TXN—hematologic cancer	7.14e-06	0.000888	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Platelet activation, signaling and aggregation—MAPK3—hematologic cancer	7.08e-06	0.000882	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism—SPHK1—hematologic cancer	6.98e-06	0.000869	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Hemostasis—MAPK14—hematologic cancer	6.96e-06	0.000866	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Platelet activation, signaling and aggregation—TGFB1—hematologic cancer	6.87e-06	0.000855	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Hemostasis—FN1—hematologic cancer	6.74e-06	0.000839	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism—UGT1A1—hematologic cancer	6.71e-06	0.000835	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism—SLC22A1—hematologic cancer	6.53e-06	0.000812	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism—CRABP1—hematologic cancer	6.53e-06	0.000812	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Hemostasis—PIK3CG—hematologic cancer	6.45e-06	0.000803	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism—ALOX5—hematologic cancer	6.36e-06	0.000792	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Hemostasis—PTPN11—hematologic cancer	6.34e-06	0.000789	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism—NUP98—hematologic cancer	6.16e-06	0.000767	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Hemostasis—CREBBP—hematologic cancer	5.98e-06	0.000745	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism—NCOA3—hematologic cancer	5.98e-06	0.000744	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism—ADCY7—hematologic cancer	5.98e-06	0.000744	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism—NUP214—hematologic cancer	5.94e-06	0.000739	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism of lipids and lipoproteins—PIK3CG—hematologic cancer	5.88e-06	0.000731	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Platelet activation, signaling and aggregation—PIK3CA—hematologic cancer	5.85e-06	0.000728	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism—ABCG2—hematologic cancer	5.82e-06	0.000724	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism—MTR—hematologic cancer	5.82e-06	0.000724	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism—ENO2—hematologic cancer	5.7e-06	0.00071	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Hemostasis—PIK3CD—hematologic cancer	5.67e-06	0.000706	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism—GSTT1—hematologic cancer	5.53e-06	0.000689	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism of lipids and lipoproteins—CREBBP—hematologic cancer	5.45e-06	0.000678	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism—SDC1—hematologic cancer	5.41e-06	0.000673	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Hemostasis—PIK3R1—hematologic cancer	5.36e-06	0.000667	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Hemostasis—JAK2—hematologic cancer	5.21e-06	0.000648	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Transmembrane transport of small molecules—CREBBP—hematologic cancer	5.18e-06	0.000645	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism of lipids and lipoproteins—PIK3CD—hematologic cancer	5.17e-06	0.000643	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Hemostasis—PIK3CB—hematologic cancer	4.95e-06	0.000616	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism of lipids and lipoproteins—PIK3R1—hematologic cancer	4.88e-06	0.000607	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Platelet activation, signaling and aggregation—AKT1—hematologic cancer	4.78e-06	0.000595	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism—CD44—hematologic cancer	4.6e-06	0.000572	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism—NQO1—hematologic cancer	4.6e-06	0.000572	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Hemostasis—IL2—hematologic cancer	4.54e-06	0.000565	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism of lipids and lipoproteins—PIK3CB—hematologic cancer	4.5e-06	0.00056	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism—CYCS—hematologic cancer	4.35e-06	0.000542	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism—HSP90AA1—hematologic cancer	4.32e-06	0.000538	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Hemostasis—EP300—hematologic cancer	4.08e-06	0.000507	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Hemostasis—SRC—hematologic cancer	3.96e-06	0.000493	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	3.89e-06	0.000484	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Hemostasis—VEGFA—hematologic cancer	3.86e-06	0.00048	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism—GSTP1—hematologic cancer	3.84e-06	0.000477	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Hemostasis—NRAS—hematologic cancer	3.81e-06	0.000475	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	3.71e-06	0.000462	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Hemostasis—MAPK3—hematologic cancer	3.65e-06	0.000454	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism—ABCB1—hematologic cancer	3.63e-06	0.000452	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Hemostasis—TGFB1—hematologic cancer	3.54e-06	0.000441	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism—GSTM1—hematologic cancer	3.52e-06	0.000439	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism—NCOR1—hematologic cancer	3.52e-06	0.000439	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Hemostasis—KRAS—hematologic cancer	3.28e-06	0.000408	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism—MTHFR—hematologic cancer	3.11e-06	0.000388	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Hemostasis—PIK3CA—hematologic cancer	3.02e-06	0.000375	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Hemostasis—TP53—hematologic cancer	2.92e-06	0.000363	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Hemostasis—HRAS—hematologic cancer	2.79e-06	0.000347	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	2.74e-06	0.000342	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism—PIK3CG—hematologic cancer	2.62e-06	0.000326	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Hemostasis—AKT1—hematologic cancer	2.46e-06	0.000307	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism—CREBBP—hematologic cancer	2.43e-06	0.000302	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism—PIK3CD—hematologic cancer	2.3e-06	0.000286	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism—PIK3R1—hematologic cancer	2.17e-06	0.00027	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism—PIK3CB—hematologic cancer	2.01e-06	0.00025	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism—PTEN—hematologic cancer	1.73e-06	0.000216	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism—EP300—hematologic cancer	1.65e-06	0.000206	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism—PIK3CA—hematologic cancer	1.22e-06	0.000152	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism—AKT1—hematologic cancer	9.99e-07	0.000124	CbGpPWpGaD
